Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Infinity Pharmaceuticals Inc

+ Add to Watchlist

INFI:US

13.7700 USD 0.7700 5.30%

As of 20:10:00 ET on 04/27/2015.

Snapshot for Infinity Pharmaceuticals Inc (INFI)

Open: 14.5600 Day's Range: 13.5400 - 14.6600 Volume: 693,773
Previous Close: 14.5400 52wk Range: 8.4000 - 18.2500 1-Yr Rtn: +47.12%

Stock Chart for INFI

No chart data available.
  • INFI:US 13.7700
  • 1D
  • 1M
  • 1Y
14.5400
Interactive INFI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INFI

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4047
Est. EPS (USD) (12/2015) -3.1880
Est. PEG Ratio -
Market Cap (M USD) 675.30
Shares Outstanding (M) 49.04
30 Day Average Volume 593,275
Price/Book (mrq) 3.2131
Price/Sale (ttm) 4.0591
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INFI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INFI

Infinity Pharmaceuticals, Inc. researches and develops cancer drugs. The Company uses small molecule drug technologies in the development of its products.

Adelene Q PerkinsChairman/President/CEOJulian AdamsPresident:Research & Dev
David A RothChief Medical OfficerVito J PalombellaChief Scientific Officer
More Company Profile & Key Executives for INFI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil